Evidence map›Paper›PMID 38401795›Full record

SynthesisValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research2024

Economic Evaluations of Establishing Opioid Overdose Prevention Centers in 12 North American Cities: A Systematic Review.

Czarina N Behrends, Jared A Leff, Weston Lowry, Jazmine M Li, Erica N Onuoha, Erminia Fardone, Ahmed M Bayoumi, Kathryn E McCollister, Sean M Murphy, Bruce R Schackman

Abstract readSystematic Review
In one paragraph

Synthesis in Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Czarina N BehrendsDepartment of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA. Electronic address: czb2002@med.cornell.edu.
Jared A LeffDepartment of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.
Weston LowryDepartment of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.
Jazmine M LiDepartment of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.
Erica N OnuohaDepartment of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.
Erminia FardoneDepartment of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Ahmed M BayoumiDepartment of Medicine and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; Division of General Internal Medicine, St. Michael's Hospital, Toronto, Ontario, Canada.
Kathryn E McCollisterDepartment of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Sean M MurphyDepartment of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.
Bruce R SchackmanDepartment of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.

Funding

Utilization of health services after engagement with opioid use disorder (OUD) treatment provider by individuals with and without post-traumatic stress disorderP30DA040500 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI ZACHARY Franklin MEISEL · 2015 to 2026
$20.7M
A comparative evaluation of overdose prevention programs in New York City and Rhode IslandR01DA058277 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Bennett Allen, Magdalena Cerda · 2023 to 2026
$5.8M
NIDA NIH HHS P30 DA040500NIDA NIH HHS R01 DA058277
6 · The paper itself

Abstract

objectivesOverdose prevention centers (OPCs) provide a safe place where people can consume preobtained drugs under supervision so that a life-saving medical response can be provided quickly in the event of an overdose. OPCs are programs that are established in Canada and have recently become legally sanctioned in only a few United States jurisdictions.

methodsWe conducted a systematic review that summarizes and identifies gaps of economic evidence on establishing OPCs in North America to guide future expansion of OPCs.

resultsWe included 16 final studies that were evaluated with the Consolidated Health Economic Evaluation Reporting Standards and Drummond checklists. Eight studies reported cost-effectiveness results (eg, cost per overdose avoided or cost per quality-adjusted life-year), with 6 also including cost-benefit; 5 reported only cost-benefit results, and 3 cost offsets. Health outcomes primarily included overdose mortality outcomes or HIV/hepatitis C virus infections averted. Most studies used mathematical modeling and projected OPC outcomes using the experience of a single facility in Vancouver, BC.

conclusionsOPCs were found to be cost-saving or to have favorable cost-effectiveness or cost-benefit ratios across all studies. Future studies should incorporate the experience of OPCs established in various settings and use a greater diversity of modeling designs.

Indexed as

Cost-Benefit AnalysisOpiate OverdoseCanadaHumansNorth AmericaQuality-Adjusted Life Yearscost-effectiveness analysisoverdose prevention centerssystematic literature review

Identifiers

PMID38401795
PMCPMC11069439

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.